Paper25979640
Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit.
Gharbi M and 6 others. Int J Antimicrob Agents, 2015. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit. Papers, record 25979640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25979640
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Disease Outbreaks | Major topic |
| Drug Utilization | Major topic |
| Klebsiella Infections | Major topic |
| Klebsiella pneumoniae | Major topic |
| Thienamycins | Major topic |
| beta-Lactamases | Major topic |
| Epidemiological Monitoring | |
| Forecasting | |
| Hospitals | |
| Humans | |
| Incidence | |
| London | |
| Meropenem | |
| Models, Statistical | |
| Retrospective Studies | |
| beta-Lactam Resistance |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| G0800777 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9710666 | Antibiotic-selective environments. | Clin Infect Dis | 1998 | https://conductscience.org/library/papers/9710666 | PubMed |
| 2 | 23489756 | Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistance. | Lancet | 2013 | https://conductscience.org/library/papers/23489756 | PubMed |
| 3 | 12174032 | Segmented regression analysis of interrupted time series studies in medication use research. | J Clin Pharm Ther | 2002 | https://conductscience.org/library/papers/12174032 | PubMed |
| 4 | 23633313 | Interventions to improve antibiotic prescribing practices for hospital inpatients. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23633313 | PubMed |
| 5 | 17376385 | The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. | Lancet Infect Dis | 2007 | https://conductscience.org/library/papers/17376385 | PubMed |
| 6 | 23750724 | Increasing prevalence of carbapenem-resistant Enterobacteriaceae and strategies to avert a looming crisis. | Expert Rev Anti Infect Ther | 2013 | https://conductscience.org/library/papers/23750724 | PubMed |
| 7 | 15095767 | Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies. | Int J Technol Assess Health Care | 2003 | https://conductscience.org/library/papers/15095767 | PubMed |
| 8 | 10717497 | Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. | Int J Antimicrob Agents | 2000 | https://conductscience.org/library/papers/10717497 | PubMed |
| 9 | 24162744 | Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States. | Clin Infect Dis | 2014 | https://conductscience.org/library/papers/24162744 | PubMed |
| 10 | 22282479 | Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT. | Clin J Am Soc Nephrol | 2012 | https://conductscience.org/library/papers/22282479 | PubMed |
| 11 | 8589129 | The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms. | Clin Infect Dis | 1995 | https://conductscience.org/library/papers/8589129 | PubMed |
| 12 | 21649882 | Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. | Crit Care | 2011 | https://conductscience.org/library/papers/21649882 | PubMed |
| 13 | 1399923 | Ciprofloxacin and Clostridium difficile-associated diarrhoea. | J Antimicrob Chemother | 1992 | https://conductscience.org/library/papers/1399923 | PubMed |
| 14 | 21303394 | Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. | FEMS Microbiol Rev | 2011 | https://conductscience.org/library/papers/21303394 | PubMed |
| 15 | 2745711 | The science of public health surveillance. | J Public Health Policy | 1989 | https://conductscience.org/library/papers/2745711 | PubMed |
| 16 | 25118270 | Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108,717 clinical isolates from primary, secondary and tertiary care patients in London. | J Antimicrob Chemother | 2014 | https://conductscience.org/library/papers/25118270 | PubMed |
| 17 | 23276500 | Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum β-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus. | Int J Antimicrob Agents | 2013 | https://conductscience.org/library/papers/23276500 | PubMed |
| 18 | 23876330 | Evaluation of a national microbiological surveillance system to inform automated outbreak detection. | J Infect | 2013 | https://conductscience.org/library/papers/23876330 | PubMed |
| 19 | 24207018 | Early (2008-2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK. | Int J Antimicrob Agents | 2013 | https://conductscience.org/library/papers/24207018 | PubMed |
| 20 | 1955267 | The use of transfer function models, intervention analysis and related time series methods in epidemiology. | Int J Epidemiol | 1991 | https://conductscience.org/library/papers/1955267 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41965560 | Dynamic regression forecasting of carbapenem-resistant Klebsiella spp. based on carbapenem consumption with observed data from 2020 to 2023 and projections up to 2029 in a tertiary hospital in Alexandria, Egypt. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/41965560 | PubMed |
| 41148713 | Correlation Between Antimicrobial Consumption and Resistance in Klebsiella pneumoniae During the COVID-19 Pandemic Using Dynamic Regression Models: A Quasi-Experimental Epidemiological Time-Series Study. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/41148713 | PubMed |
| 40724573 | Which Classes of Antibiotics Are Associated with the Acquisition of Carbapenemase-Producing Enterobacterales? | Life (Basel) | 2025 | https://conductscience.org/library/papers/40724573 | PubMed |
| 39754681 | Long-term forecast for antibacterial drug consumption in Germany using ARIMA models. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39754681 | PubMed |
| 39487661 | Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. | Health Technol Assess | 2024 | https://conductscience.org/library/papers/39487661 | PubMed |
| 38938145 | Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. | Health Technol Assess | 2024 | https://conductscience.org/library/papers/38938145 | PubMed |
| 37697357 | Usefulness of dynamic regression time series models for studying the relationship between antimicrobial consumption and bacterial antimicrobial resistance in hospitals: a systematic review. | Antimicrob Resist Infect Control | 2023 | https://conductscience.org/library/papers/37697357 | PubMed |
| 36694849 | Systematic review of time lag between antibiotic use and rise of resistant pathogens among hospitalized adults in Europe. | JAC Antimicrob Resist | 2023 | https://conductscience.org/library/papers/36694849 | PubMed |
| 36422214 | An Overview on Phenotypic and Genotypic Characterisation of Carbapenem-Resistant Enterobacterales. | Medicina (Kaunas) | 2022 | https://conductscience.org/library/papers/36422214 | PubMed |
| 35856662 | OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/35856662 | PubMed |
| 34948564 | Extended-Spectrum Beta-Lactamase-Producing and Carbapenem-Resistant Enterobacterales in Companion and Animal-Assisted Interventions Dogs. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/34948564 | PubMed |
| 33299948 | Implementation of an infection control program with emphasis on cohorting to patients with carbapenemase-producing Enterobacteriaceae. The experience of 2 years in a tertiary teaching hospital in northern Portugal. | Porto Biomed J | 2020 | https://conductscience.org/library/papers/33299948 | PubMed |
| 31988746 | Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study. | Antimicrob Resist Infect Control | 2020 | https://conductscience.org/library/papers/31988746 | PubMed |
| 31771707 | Antibiotic consumption in Belgian acute care hospitals: analysis of the surveillance methodology, consumption evolution 2003 to 2016 and future perspectives. | Euro Surveill | 2019 | https://conductscience.org/library/papers/31771707 | PubMed |
| 31722889 | The Global Ascendency of OXA-48-Type Carbapenemases. | Clin Microbiol Rev | 2019 | https://conductscience.org/library/papers/31722889 | PubMed |
| 31276536 | Quantifying uncertainty about future antimicrobial resistance: Comparing structured expert judgment and statistical forecasting methods. | PLoS One | 2019 | https://conductscience.org/library/papers/31276536 | PubMed |
| 30568986 | Semi-Automated Visualization and ANalysis of Trends: A "SAVANT" for Facilitating Antimicrobial Stewardship Using Antistaphylococcal Resistance and Consumption as a Prototype. | Open Forum Infect Dis | 2018 | https://conductscience.org/library/papers/30568986 | PubMed |
| 29739906 | Ceftazidime Is the Key Diversification and Selection Driver of VIM-Type Carbapenemases. | mBio | 2018 | https://conductscience.org/library/papers/29739906 | PubMed |
| 29458443 | Epidemiology and control measures of an OXA-48-producing Enterobacteriaceae hospital-wide oligoclonal outbreak. | Epidemiol Infect | 2018 | https://conductscience.org/library/papers/29458443 | PubMed |
| 29177610 | Findings from an outbreak of carbapenem-resistant Klebsiella pneumoniae emphasize the role of antibiotic treatment for cross transmission. | Infection | 2018 | https://conductscience.org/library/papers/29177610 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25979640
GET https://conductscience.org/api/papers/v1/25979640/references?page=2